Exposure of the heart in breast cancer radiation therapy: A systematic review of heart doses published during 2003 to 2013

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 4, 2015, Pages 845-853

  Taylor, Carolyn W ^a   Zhe, Wang ^a   Macaulay, Elizabeth ^b   Jagsi, Reshma ^c   Duane, Frances ^a   Darby, Sarah C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Department of Paediatrics Horton General Hospital   (United Kingdom)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; HEART; PROTON BEAM THERAPY; RADIATION;

ARITHMETIC MEAN; BREAST CANCER; HEART DISEASE; INTENSITY MODULATED RADIATION THERAPY; METHODS AND MATERIALS; PROTON RADIATION THERAPY; SYSTEMATIC REVIEW; TARGET TISSUES;

RADIOTHERAPY;

BREAST CANCER; CANCER RADIOTHERAPY; DECUBITUS; DOSIMETRY; HUMAN; INFORMATION RETRIEVAL; INTENSITY MODULATED RADIATION THERAPY; MEAN HEART DOSE; PRIORITY JOURNAL; PROTON THERAPY; PUBLICATION; RADIATION DOSE; RADIATION EXPOSURE; RESPIRATION CONTROL; REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TARGET ORGAN; CARDIOTOXICITY; FEMALE; HEART; ORGANS AT RISK; RADIATION RESPONSE; RADIOTHERAPY; STATISTICS AND NUMERICAL DATA; UNILATERAL BREAST NEOPLASMS;

CARDIOTOXICITY; FEMALE; HEART; HUMANS; LYMPHATIC IRRADIATION; ORGANS AT RISK; PROTON THERAPY; RADIATION DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; UNILATERAL BREAST NEOPLASMS;

EID: 84948444571     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.07.2292     Document Type: Article

References (21)

1. . Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-Analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:2127-2135.
2. . Early Breast Cancer Trialist s' Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-Analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011;378:1 707-1716.
3. National Cancer Institute. Cancer trends progress report. Bethesda MD: NCI/NIH/DHH 2012. Available at http://progressreport.cancer.gov/treatment/breast-cancer#field-most-recent-estimates. Accessed March 1 0, 2015.
4. . Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-2106.
5. . Darby SC, McGale P, Taylor CW, et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557-565.
6. . Giordano SH, Kuo YF, Freeman JL, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97: 419-424.
7. . Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368:987-998.
8. . Taylor CW, Nisbet A, McGale P, et al. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007; 69:1484-1495.
9. . van der Laan HP, Hurkmans CW, Kuten A, et al. Current technological clinical practice in breast radiotherapy: Results of a survey in EORTCRadiation Oncology Group affiliated institutions. Radiot her Oncol 2010;94:280-285.
10. . Lohr F, El-Haddad M, Dobler B, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 2009;74:73-80.
11. . Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Website. Available at: http://www.prisma-statement.org/. Accessed July 2, 2015.
12. . World Health Organization. Health statistics and information systems. Available at: http://www.who.int/healthinfo/global-burden-disease/definition-regions/en/. Accessed March 30, 2015.
13. . Yin Y, Chen J, Sun T, et al. Dosimetric research on intensitymodulated arc radiotherapy planning for left breast cancer after breast-preservation surgery. Med Dosim 2012;37:287-292.
14. . Caudell JJ, De L os Santos JF, Keene KS, et al. A dosimetric comparison of electronic compensation, conventional intensity modulated radiotherapy, and tomotherapy in patients with earlystage carcinoma of the left breast. Int J Radiat Oncol Biol Phys 2007;68:1505-1511.
15. . De Ruysscher D, Mark Lodge M, Jones B, et al. Charged particles in radiotherapy: A 5-year update of a systematic review. Radiother Oncol 2012;103:5-7.
16. . Jagsi R, Moran J, Marsh R, et al. Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys 2010;78: 1594-1603.
17. . Nissen HD, Appelt AL. Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 2012;106:28-32.
18. McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011;100:167-175.
19. . Das SK, Baydush AH, Zhou S, et al. Predicting radiotherapy-induced cardiac perfusion defects. Med Phys 2005;32:19-27.
20. . Wei X, Liu HH, Tucker SL, et al. Risk factor s for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 2008;70:707-714.
21. . Cutter DJ, Schaapveld M, Darby SC, et al. Risk for valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst 2015;107. djv008. http://dx.doi.org/10.1093/jnci/djv008.